These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33058388)

  • 1. Understanding the opposite effects of sex hormones in mediating renal injury.
    Lima-Posada I; Bobadilla NA
    Nephrology (Carlton); 2021 Mar; 26(3):217-226. PubMed ID: 33058388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
    Swartling O; Rydell H; Stendahl M; Segelmark M; Trolle Lagerros Y; Evans M
    Am J Kidney Dis; 2021 Aug; 78(2):190-199.e1. PubMed ID: 33434591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease.
    Carrero JJ; Hecking M; Chesnaye NC; Jager KJ
    Nat Rev Nephrol; 2018 Mar; 14(3):151-164. PubMed ID: 29355169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadal Hormones in the Pathogenesis and Treatment of Bone Health in Patients with Chronic Kidney Disease: a Systematic Review and Meta-Analysis.
    Aleksova J; Rodriguez AJ; McLachlan R; Kerr P; Milat F; Ebeling PR
    Curr Osteoporos Rep; 2018 Dec; 16(6):674-692. PubMed ID: 30328552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis.
    Weldegiorgis M; Woodward M
    BMC Nephrol; 2020 Nov; 21(1):506. PubMed ID: 33238919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gender and gender disparities in patients with kidney disease.
    Brar A; Markell M
    Curr Opin Nephrol Hypertens; 2019 Mar; 28(2):178-182. PubMed ID: 30652978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.
    Muiesan ML; Ambrosioni E; Costa FV; Leonetti G; Pessina AC; Salvetti M; Trimarco B; Volpe M; Pontremoli R; Deferrari G; Rosei EA
    J Hypertens; 2012 Dec; 30(12):2378-86. PubMed ID: 23137952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differences between men and women with chronic kidney disease].
    Suzuki H
    Nihon Rinsho; 2015 Apr; 73(4):629-33. PubMed ID: 25936152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-Related Disparities in CKD Progression.
    Ricardo AC; Yang W; Sha D; Appel LJ; Chen J; Krousel-Wood M; Manoharan A; Steigerwalt S; Wright J; Rahman M; Rosas SE; Saunders M; Sharma K; Daviglus ML; Lash JP;
    J Am Soc Nephrol; 2019 Jan; 30(1):137-146. PubMed ID: 30510134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex hormones and their influence on chronic kidney disease.
    Valdivielso JM; Jacobs-Cachá C; Soler MJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):1-9. PubMed ID: 30320621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis.
    Shen Y; Cai R; Sun J; Dong X; Huang R; Tian S; Wang S
    Endocrine; 2017 Jan; 55(1):66-76. PubMed ID: 27477292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis.
    Cobo G; Hecking M; Port FK; Exner I; Lindholm B; Stenvinkel P; Carrero JJ
    Clin Sci (Lond); 2016 Jul; 130(14):1147-63. PubMed ID: 27252402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogens and the heart.
    Rosano GM; Panina G
    Therapie; 1999; 54(3):381-5. PubMed ID: 10500455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogens and the diabetic kidney.
    Maric C; Sullivan S
    Gend Med; 2008; 5 Suppl A(Suppl A):S103-13. PubMed ID: 18395675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune cells and inflammation in AKI to CKD progression.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1501-F1512. PubMed ID: 30156114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of subnormal testosterone concentrations in men with type 2 diabetes and chronic kidney disease.
    Dhindsa S; Reddy A; Karam JS; Bilkis S; Chaurasia A; Mehta A; Raja KP; Batra M; Dandona P
    Eur J Endocrinol; 2015 Sep; 173(3):359-66. PubMed ID: 26101371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD.
    Kruse NT
    Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R719-R732. PubMed ID: 31577157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.